Bombay-Burmah (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance … | |||||||||||||||
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance regarding significant increase in trading volumes. All companies confirmed compliance with disclosure requirements and stated no price-sensitive information was withheld.
| |||||||||||||||
BSE announces listing of Rs. 250 crore commercial paper issued by The Bombay Burmah Trading Corporation Ltd. with IND A1+ rating, maturing … | |||||||||||||||
BSE announces listing of Rs. 250 crore commercial paper issued by The Bombay Burmah Trading Corporation Ltd. with IND A1+ rating, maturing on November 12, 2026.
| |||||||||||||||
BSE announces an amendment in the corporate name of Bombay Burmah Trading Corporation Ltd (Scrip code: 501425). | |||||||||||||||
BSE announces an amendment in the corporate name of Bombay Burmah Trading Corporation Ltd (Scrip code: 501425).
| |||||||||||||||
BSE announces the amendment in the name of Bombay Burmah Trading Corporation Ltd. | |||||||||||||||
BSE announces the amendment in the name of Bombay Burmah Trading Corporation Ltd.
| |||||||||||||||
BSE circular regarding amendment or change in the name of Bombay Burmah Trading Corporation Ltd with scrip code 501425. | |||||||||||||||
BSE circular regarding amendment or change in the name of Bombay Burmah Trading Corporation Ltd with scrip code 501425.
| |||||||||||||||